Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-14

Clinical Trial Update: AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AM-125 for acute peripheral vertigo after neurosurgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AM-125

Snippet

Sponsor: Auris Medical AG | Conditions: Vestibular Vertigo | Phase 2 | Status: COMPLETED